Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
Overwijk WW, de Visser KE, Tirion FH, de Jong LA, Pols TW, van der Velden YU, van den Boorn JG, Keller AM, Buurman WA, Theoret MR, Blom B, Restifo NP, Kruisbeek AM, Kastelein RA, Haanen JB.
Overwijk WW, et al. Among authors: theoret mr.
J Immunol. 2006 May 1;176(9):5213-22. doi: 10.4049/jimmunol.176.9.5213.
J Immunol. 2006.
PMID: 16621986
Free PMC article.